• USCAP BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology 2023

USCAP BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology 2023

USCAP BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology 2023

$100.00 USD
$100.00 USD
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
USCAP BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology 2023

USCAP BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology 2023

$100.00
$100.00
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out

  • Share positive thoughts and feedback from your customer.

    Author

  • Share positive thoughts and feedback from your customer.

    Author

  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology (Uscap Course)

    USCAP BELOW THE BELT: Pitfalls and New Entities in Anorectal, Urologic and Gynecologic Surgical Pathology and Cytopathology 2023 Pathology of the lower anogenital tract, lower urinary tract, prostate, uterus, and cervix has advanced with the identification of relevant genes, better immunohistochemical markers, and the ability to readily detect human papillomavirus (HPV) using RNA in situ hybridization.
    New entities have recently been recognized, refinements to existing ones are possible, and new treatment, particularly immunotherapy, are available. Expert faculty will discuss newer entities and pitfalls in these areas, while also addressing diagnostic challenges in cytology and newly adopted classification schemes.
    Pathology of the lower anogenital tract, lower urinary tract, prostate, uterus, and cervix has advanced with the identification of relevant genes, better immunohistochemical markers, and the ability to readily detect human papillomavirus (HPV) using RNA in situ hybridization. New entities have recently been recognized, refinements to existing ones are possible, and new treatment, particularly immunotherapy, are available. Expert faculty will discuss newer entities and pitfalls in these areas, while also addressing diagnostic challenges in cytology and newly adopted classification schemes.
    Target Audience
    Practicing academic and community pathologists, and pathologists-in-training

    Learning Objectives

    • Upon completion of this educational activity, learners will be able to:
    •  Discuss novel recently described human papilloma virus (HPV)-associated and HPV-independent neoplasms of the lower genital tract
    •  Present a modern viewpoint for grading prostatic carcinoma
    •  Address pitfalls in diagnosing urothelial neoplasms versus those from adjoining sites, including treatment related pitfalls
    •  Consider mimickers of common neoplasms of the anogenital and urothelial tracts
    •  Establish systematic approach to diagnostic challenges in cytology

    Program

    • Items Included in the Purchase of this Course
    • - Male Genital Tract Infernos - Sara E. Wobker MD, MPH
    • - Lower Gastrointestinal Tract Infernos - Elizabeth Montgomery, MD
    • - Female Genital Tract Infernos - Andre Pinto, MD
    • - Cytologic Infernos - Christopher J. VandenBussche, MD
    • - Male Genital Tract Mirages - Sara E. Wobker MD, MPH
    • - Lower Gastrointestinal Tract Mirages - Elizabeth Montgomery, MD
    • - Female Genital Tract Mirages - Andre Pinto, MD
    • - Cytologic Mirages - Christopher J. VandenBussche, MD
    Original release date: May 16, 2023
    Format : 8 MP4 + 8 PDF files
    File Size : 40.8 GB